Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis

Arno Verleye, Veerle Wijtvliet, Steven Abrams, Rachel Hellemans, Rania Bougrea, Annick Massart, Lissa Pipeleers, Karl Martin Wissing, Kevin K Ariën, Benedicte Y De Winter, Pierre Van Damme, Daniel Abramowicz, Kristien J Ledeganck

Research output: Contribution to journalA1: Web of Science-articlepeer-review

Abstract

BACKGROUND: In the general population, the seroconversion rate after primary vaccination with two doses of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA (mRNA) vaccine reaches nearly 100%, with significantly higher antibody titers after mRNA-1273 vaccination compared to BNT162b2 vaccination. Here we performed a systematic review and meta-analysis to compare the antibody response after two-dose mRNA-1273 versus BNT162b2 vaccination in solid organ transplant (SOT) recipients.

METHODS: A systematic literature review was performed using PubMed, Web of Science and the Cochrane Library and original research papers were included for a meta-analysis to calculate vaccine-specific seroconversion rates for each of the mRNA vaccines. Next, the pooled relative seroconversion rate was estimated.

RESULTS: Eight studies that described the development of antibodies against receptor-binding domain (RBD) and/or spike protein were eligible for meta-analysis. Two of these studies also reported antibody titers. The meta-analysis revealed lower seroconversion rates in SOT recipients vaccinated with two doses of BNT162b2 {44.3% [95% confidence interval (CI) 34.1-54.7]} as compared with patients vaccinated with two doses of mRNA-1273 [58.4% (95% CI 47.2-69.2)]. The relative seroconversion rate was 0.795 (95% CI 0.732-0.864).

CONCLUSIONS: This systematic review and meta-analysis indicates that in SOT recipients, higher seroconversion rates were observed after vaccination with mRNA-1273 compared with BNT162b2.

Original languageEnglish
JournalNephrology, Dialysis, Transplantation
Volume37
Issue number8
Pages (from-to)1566-1575
Number of pages10
ISSN0931-0509
DOIs
Publication statusPublished - 2022

Keywords

  • 2019-nCoV Vaccine mRNA-1273
  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19/prevention & control
  • Humans
  • Organ Transplantation
  • RNA, Messenger
  • Seroconversion
  • Transplant Recipients
  • Vaccination
  • Vaccines

Fingerprint

Dive into the research topics of 'Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this